Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/15/2017 02/16/2017 02/17/2017 02/21/2017 02/22/2017 Date
1.13(c) 1.12(c) 1.15(c) 1.13(c) 1.12 Last
139 791 279 508 374 021 193 706 183 012 Volume
-0.88% -0.88% +2.68% -1.74% -0.89% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -20,6 M
Net income 2016 -19,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -24,6 M
Net income 2017 -24,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 93,8 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder.The... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
06:11p CATALYST PHARMACEUTICALS, INC. (NASD : CPRX) Files SEC Prospectus
02/09 CATALYST PHARMACEUTICALS : Announces Participation at SunTrust Robinson Humphrey..
02/09 Catalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphre..
01/20 CATALYST PHARMACEUTICALS (NASDAQ : CPRX) Offering Novel Therapies for Rare Disea..
2016 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
2016 Catalyst Pharmaceuticals Announces First Patient Enrolled in Second Phase 3 T..
2016 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
2016 Catalyst Pharmaceuticals Provides Update on its Clinical Trial for Patients w..
2016 CATALYST PHARMACEUTICALS : to Participate in the 28th Annual Piper Jaffray Healt..
2016 CATALYST PHARMACEUTICALS, INC. (NASD : CPRX) Files An 8-K Announces Third Quarte..
More news
Sector news : Bio Therapeutic Drugs
09:10p Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
More sector news : Bio Therapeutic Drugs
Latest Tweets
06:15p$CPRX Files SEC Prospectus  
06:15p$CPRX Files SEC Prospectus  
06:15p$CPRX Files SEC Prospectus  
06:15p$CPRX Files SEC Prospectus  
06:15p$CPRX Files SEC Prospectus  
More tweets
Qtime:28
News from SeekingAlpha
01/04 CATALYST PHARMACEUTICALS : Why This $1 Biotech Stock Is A Strong Buy For 2017
2016 Midday Gainers / Losers
2016 Enrollment underway in Catalyst Pharma's second late-stage study of Firdapse ..
2016 Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q3 2016 Resul..
2016 Catalyst Pharmaceutical beats by $0.01
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 4,38 $
Spread / Average Target 287%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Patrick J. McEnany Chairman, President & Chief Executive Officer
Steven R. Miller Chief Operating & Scientific Officer
Alicia Grande Chief Financial Officer, Treasurer & VP
Gary Ingenito Chief Medical Officer & Head-Regulatory Affairs
Philip H. Coelho Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CATALYST PHARMACEUTICA..7.62%94
AMGEN, INC.18.42%127 509
CELGENE CORPORATION3.19%92 920
GILEAD SCIENCES, INC.-3.24%91 287
REGENERON PHARMACEUTIC..1.23%39 421
ACTELION LTD22.45%28 891
More Results